Skip to main navigation
Skip to search
Skip to main content
University College Cork Home
Home
Profiles
Research units
Research output
Activities
Prizes
Datasets
Impacts
Courses
Press/Media
Search by expertise, name or affiliation
The effectiveness of Reslizumab in severe asthma treatment: A real-world experience
H. Ibrahim
, R. O'Sullivan
, D. Casey
, J. Murphy
,
J. MacSharry
, B. J. Plant
, D. M. Murphy
School of Microbiology
APC Microbiome Ireland
University College Cork
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The effectiveness of Reslizumab in severe asthma treatment: A real-world experience'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Asthma
100%
Reslizumab
100%
Severe Asthma
100%
Eosinophilic
66%
Clinical Trial
33%
Respiratory Tract Inflammation
33%
Eosinophil
33%
Sputum
33%
Interleukin 5
33%
Prednisolone
33%
Creatine Kinase
33%
Oral
33%
Side Effect
33%
Immunology and Microbiology
Asthma
100%
Severe Asthma
100%
Reslizumab
100%
Airway
33%
Interleukin 5
33%
Eosinophil
33%
Sputum
33%
Prednisolone
33%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Reslizumab
100%
Clinical Trial
20%
Respiratory Tract Inflammation
20%
Creatine Kinase
20%
Prednisolone
20%
Interleukin 5
20%
Side Effect
20%